TMO May 17th Options Begin Trading

Investors in Thermo Fisher Scientific Inc ( TMO) saw new options begin trading today, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TMO options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

The put contract at the $115.00 strike price has a current bid of $1.10. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $115.00, but will also collect the premium, putting the cost basis of the shares at $113.90 (before broker commissions). To an investor already interested in purchasing shares of TMO, that could represent an attractive alternative to paying $121.31/share today.

Because the $115.00 strike represents an approximate 5% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 74%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.96% return on the cash commitment, or 6.47% annualized — at Stock Options Channel we call this the YieldBoost.

START SLIDESHOW:
Top YieldBoost Puts of Stocks Analysts Like »

Below is a chart showing the trailing twelve month trading history for Thermo Fisher Scientific Inc, and highlighting in green where the $115.00 strike is located relative to that history:

If you liked this article you might like

Jim Cramer: Agilent Technology Has Been One of My Favorites

Secondaries Get Primary Attention; Discerning Market -- Cramer's Top Thoughts

Cramer: Secondary Offerings Get Primary Attention

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria